Island Pharma Jumps After Emergency-Use Approval for Ebola Drug

Australia’s Island Pharmaceuticals Ltd. surged as much as 47% after saying its experimental antiviral galidesivir had secured regulatory and ethics approvals for emergency use in patients with the Bundibugyo strain of Ebola in Uganda.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.